ResMed logo
ResMed
RMD | NYSE
Chart Builder DCF Calculator
$238.19
-$1.34 (-0.56%)
At close: Nov 16, 2026, 4:00 PM ET
$238.94
+$0.75 (+0.31%)
After-hours: Nov 16, 2026, 7:37 PM ET

ResMed Company Profile

Company profile explained

Company Profile

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

Key Executives

Name Position
Keith Serzen Senior Advisor to the CEO
Michael J. Farrell Chief Executive Officer & Chairman
Aaron Bloomer Chief Financial Officer
Alastair Robertson Chief Information Officer
Michael Rider Chief Legal Officer & Secretary
Vered Keisar Chief People Officer
Yvonne-Katrin Pucknat Chief Marketing Officer
Brett A. Sandercock Advisor
Carlos Nunez Chief Medical Officer
Jim Ellis Chief Compliance Officer
Justin Leong Chief Product Officer
Michael Fliss Chief Revenue Officer
Peter C. Farrell Founder, Chair Emeritus & Non-Executive Director
Sallilyn Schwartz Chief Communications and Investor Relations Officer
Shane Azzi Chief Supply Chain Officer
Todd Friedman Chief Information Security Officer

Latest SEC Filings

Date Type Title
Oct 30, 2026 10-Q Quarterly Report
Oct 29, 2026 8-K Current Report
Oct 26, 2026 4 Filing
Oct 08, 2026 4 Filing
Oct 01, 2026 ARS Filing
Oct 01, 2026 DEFA14A Filing
Oct 01, 2026 DEF 14A Filing
Oct 01, 2026 4/A [Amend] Filing
Oct 01, 2026 4 Filing
Oct 01, 2026 4 Filing
View All SEC Filings ➞
ResMed
ResMed logo
Country United States
IPO Date Jun 2, 1995
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 11,370
CEO Michael J. Farrell

Contact Details

9001 Spectrum Center Boulevard San Diego, California 92123 United States

Stock Details

Ticker Symbol RMD
Exchange NYSE
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000943819
CUSIP Number 761152107
ISIN Number US7611521078
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.